15.02.2013 Views

world cancer report - iarc

world cancer report - iarc

world cancer report - iarc

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

MOLECULAR EPIDEMIOLOGY<br />

In 1982, “molecular <strong>cancer</strong> epidemiology”<br />

was defined as “an approach in which<br />

advanced laboratory methods are used in<br />

combination with analytic epidemiology to<br />

identify at the biochemical or molecular<br />

level specific exogenous and/or host factors<br />

that play a role in human <strong>cancer</strong> causation”<br />

(Perera FP, Weinstein IB, J Chron<br />

Dis 35: 58l-600, 1982). Four categories of<br />

biomarkers were described: internal dose,<br />

biologically effective dose, response, and<br />

susceptibility. The hope was that, by introducing<br />

biomarkers into epidemiology,<br />

researchers “should be able to predict<br />

human risks more precisely than hitherto<br />

possible”. Since then, molecular <strong>cancer</strong><br />

epidemiology has evolved rapidly, with<br />

special programmes in many schools of<br />

public health.<br />

The stated goal of molecular <strong>cancer</strong> epidemiology<br />

is the prevention of <strong>cancer</strong>.<br />

Considerable molecular epidemiologic<br />

research has focused on environmental<br />

causes because many lines of evidence<br />

indicate that the factors that determine<br />

the great majority of <strong>cancer</strong>s incidence<br />

are largely exogenous and hence preventable<br />

(Lichenstein P et al., N Engl J Med<br />

343: 78-85, 2000). These include exposures<br />

related to lifestyle and occupation,<br />

and pollutants in air, water, and the food<br />

supply. This awareness has lent greater<br />

urgency to the search for more powerful<br />

tools in the form of early-warning systems<br />

to identify causal environmental agents<br />

and flag risks well before the malignant<br />

process is entrenched.<br />

other organochlorine pesticides cause<br />

liver <strong>cancer</strong> in rats. DDT in particular<br />

has been associated with increased risk<br />

of pancreatic <strong>cancer</strong>, breast <strong>cancer</strong>,<br />

lymphoma and leukaemia in humans.<br />

Some organochlorines exhibit sex<br />

steroid activity in relevant assay systems,<br />

and these pesticides are consid-<br />

EXPOSURE<br />

ASSESSMENT MARKERS OF DOSE<br />

EARLY DETECTION & CLINICAL<br />

POPULATION<br />

STATISTICS<br />

TO HUMANS<br />

PROGNOSTIC MARKERS DISEASE<br />

Environmental<br />

or<br />

endogenous<br />

agents<br />

Absorption<br />

Distribution<br />

Metabolism<br />

Metabolites<br />

in body fluid<br />

& excreta<br />

Potential molecular endpoints (specified in the lower section) that may serve as the basis for molecular epidemiological<br />

studies. These endpoints may be indicative of biological processes contributing to <strong>cancer</strong> development<br />

as shown in the upper section.<br />

The potential contribution of molecular epidemiology<br />

includes: providing evidence<br />

that environmental agents pose carcinogenic<br />

risks, helping establish the causal<br />

roles of environmental factors in <strong>cancer</strong>,<br />

identifying environment-susceptibility<br />

interactions and populations at greatest<br />

risk and developing new intervention<br />

strategies. A recent review of the field<br />

(Perera F, J Natl Cancer Inst, 92: 602-612,<br />

2000) critically evaluated the progress to<br />

date using as illustration research on<br />

tobacco smoke, polycyclic aromatic hydrocarbons,<br />

aflatoxin B 1, benzene and hepatitis<br />

B virus and their role in lung, breast,<br />

liver <strong>cancer</strong> and leukaemia. It concluded<br />

ered to have the potential to disrupt<br />

endocrine-regulated homeostasis.<br />

Attempts have been made to correlate<br />

levels of organochlorines and polychlorinated<br />

biphenyls in breast tissue with<br />

breast <strong>cancer</strong> risk in several communities,<br />

but without clear-cut results [8].<br />

For the major pesticides, international<br />

PRIMARY PREVENTION AND CLINICAL INTERVENTIONS<br />

DNA adducts,<br />

protein adducts<br />

Repair<br />

Replication<br />

Mutation in<br />

<strong>report</strong>er genes,<br />

oncogenes,<br />

supressor genes<br />

SUSCEPTIBILITY FACTORS<br />

genetic/environmental<br />

Cell proliferation<br />

Clonal expansion<br />

Genomic<br />

instability,<br />

abberrant gene<br />

expression,<br />

altered<br />

cell structure<br />

Further<br />

genetic<br />

change<br />

Malignant<br />

tumour<br />

that molecular epidemiology has identified<br />

a number of carcinogenic hazards, in<br />

some cases providing definitive etiologic<br />

data, furthering our understanding of individual<br />

genetic and acquired susceptibility<br />

to environmental carcinogens. However,<br />

molecular epidemiology has not yet led to<br />

broad policy changes to prevent or to<br />

reduce exposure to carcinogens. What is<br />

now needed is timely translation of existing<br />

data into risk assessment and public<br />

health policy as well as focused research<br />

to fill gaps in scientific knowledge.<br />

regulations exist with regard to permissible<br />

amounts of residues in foods – the<br />

ADI, or acceptable daily intake, being<br />

the primary reference level for such<br />

exposures. ADI levels are determined by<br />

expert groups convened by WHO, and<br />

published as the WHO Pesticide Residue<br />

Series.<br />

Food contaminants 45

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!